iTeos to Participate in Upcoming Investor Conferences
March 01 2024 - 7:00AM
iTeos Therapeutics, Inc. (Nasdaq: ITOS), a clinical-stage
biopharmaceutical company pioneering the discovery and development
of a new generation of immuno-oncology therapeutics for patients,
today announced that company management will participate in two
upcoming investor conferences in March:
Cowen 44th Annual Healthcare Conference Format:
Presentation and one-on-one investor meetingsDate: Wednesday, March
6, 2024Time: 1:30 PM ETLocation: Boston, M.A.
Leerink Partners Global Biopharma
ConferenceFormat: One-on-one investor meetingsDate: Monday, March
11, 2024Location: Miami, F.L.
A live webcast of the conference presentation
will be available on the Investors section of the company’s website
at www.iteostherapeutics.com. An archived replay will be available
for approximately 30 days following the presentation.
About iTeos Therapeutics,
Inc.
iTeos Therapeutics is a clinical-stage
biopharmaceutical company pioneering the discovery and development
of a new generation of immuno-oncology therapeutics for patients.
iTeos Therapeutics leverages its deep understanding of tumor
immunology and immunosuppressive pathways to design novel product
candidates with the potential to restore the immune response
against cancer. The Company’s innovative pipeline includes three
clinical-stage programs targeting novel, validated immuno-oncology
pathways designed with optimized pharmacologic properties for
improved clinical outcomes, including the TIGIT:CD226 axis and the
adenosine pathway. iTeos Therapeutics is headquartered in
Watertown, MA with a research center in Gosselies, Belgium.
Internet Posting of
Information
iTeos Therapeutics routinely posts information
that may be important to investors in the 'Investors' section of
its website at www.iteostherapeutics.com. The company encourages
investors and potential investors to consult our website regularly
for important information about iTeos Therapeutics.
For further information, please
contact:
Investor Contact:
Carl MauchiTeos Therapeutics,
Inc.carl.mauch@iteostherapeutics.com
Media Contact:
media@iteostherapeutics.com
iTeos Therapeutics (NASDAQ:ITOS)
Historical Stock Chart
From Jul 2024 to Aug 2024
iTeos Therapeutics (NASDAQ:ITOS)
Historical Stock Chart
From Aug 2023 to Aug 2024